Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation
Yutao Guo,Deirdre A Lane,Limin Wang,Hui Zhang,Hao Wang,Wei Zhang,Jing Wen,Yunli Xing,Fang Wu,Yunlong Xia,Tong Liu,Fan Wu,Zhaoguang Liang,Fan Liu,Yujie Zhao,Rong Li,Xin Li,Lili Zhang,Jun Guo,Girvan Burnside,Yundai Chen,Gregory Y H Lip,mAF-App II Trial Investigators,Liming Wang,Jens Eckstein,G Neil Thomas,Liu Tong,Feng Mei,Liu Xuejun,Li Xiaoming,Shan Zhaoliang,Shi Xiangming,Zhang Wei,Xing Yunli,Wen Jing,Wu Fan,Yang Sitong,Jin Xiaoqing,Yang Bo,Bai Xiaojuan,Jiang Yuting,Liu Yangxia,Song Yingying,Tan Zhongju,Yang Li,Luan Tianzhu,Niu Chunfeng,Zhang Lili,Li Shuyan,Wang Zulu,Xv Bing,Liu Liming,Jin Yuanzhe,Xia Yunlong,Chen Xiaohong,Wu Fang,Zhong Lina,Sun Yihong,Jia Shujie,Li Jing,Li Nan,Li Shijun,Liu Huixia,Li Rong,Liu Fan,Ge Qingfeng,Guan Tianyun,Wen Yuan,Li Xin,Ren Yan,Chen Xiaoping,Chen Ronghua,Shi Yun,Zhao Yulan,Shi Haili,Zhao Yujie,Wang Quanchun,Sun Weidong,Wei Lin,Esther Chan,Shan Guangliang,Yao Chen,Zong Wei,Chen Dandi,Han Xiang,Xu Anding,Fan Xiaohan,Yu Ziqiang,Gu Xiang,Ge Fulin
DOI: https://doi.org/10.1016/j.jacc.2020.01.052
2020-04-07
Abstract:Background: Current management of patients with atrial fibrillation (AF) is limited by low detection of AF, non-adherence to guidelines, and lack of consideration of patients' preferences, thus highlighting the need for a more holistic and integrated approach to AF management. Objective: The objective of this study was to determine whether a mobile health (mHealth) technology-supported AF integrated management strategy would reduce AF-related adverse events, compared with usual care. Methods: This is a cluster randomized trial of patients with AF older than 18 years of age who were enrolled in 40 cities in China. Recruitment began on June 1, 2018 and follow-up ended on August 16, 2019. Patients with AF were randomized to receive usual care, or integrated care based on a mobile AF Application (mAFA) incorporating the ABC (Atrial Fibrillation Better Care) Pathway: A, Avoid stroke; B, Better symptom management; and C, Cardiovascular and other comorbidity risk reduction. The primary composite outcome was a composite of stroke/thromboembolism, all-cause death, and rehospitalization. Rehospitalization alone was a secondary outcome. Cardiovascular events were assessed using Cox proportional hazard modeling after adjusting for baseline risk. Results: There were 1,646 patients allocated to mAFA intervention (mean age, 67.0 years; 38.0% female) with mean follow-up of 262 days, whereas 1,678 patients were allocated to usual care (mean age, 70.0 years; 38.0% female) with mean follow-up of 291 days. Rates of the composite outcome of 'ischemic stroke/systemic thromboembolism, death, and rehospitalization' were lower with the mAFA intervention compared with usual care (1.9% vs. 6.0%; hazard ratio [HR]: 0.39; 95% confidence interval [CI]: 0.22 to 0.67; p < 0.001). Rates of rehospitalization were lower with the mAFA intervention (1.2% vs. 4.5%; HR: 0.32; 95% CI: 0.17 to 0.60; p < 0.001). Subgroup analyses by sex, age, AF type, risk score, and comorbidities demonstrated consistently lower HRs for the composite outcome for patients receiving the mAFA intervention compared with usual care (all p < 0.05). Conclusions: An integrated care approach to holistic AF care, supported by mHealth technology, reduces the risks of rehospitalization and clinical adverse events. (Mobile Health [mHealth] technology integrating atrial fibrillation screening and ABC management approach trial; ChiCTR-OOC-17014138).